Adoption is the key to almost any drug or platform. MNKD has been beaten back after approval and partnership because the market has been touting all the negatives of the product. Its downright criminal when it could be key for so many people. SNY had no intention of a massive roll out from the get go, but a slow and steady approach like the tortoise vs the hare. Let the users speak for the product.
The user community has spoken and the results are a resounding YES to those that have started to use the product. It doesn't matter that only $1+ million was sold in the first 2 months, but rather how was the product tolerated and accepted. Its really that simple and its like the movie Field of Dreams "if you build it they will come." Al has built it and they will come.
News 
Market Data 
Discover 
